Cerus Current Ratio 2006-2019 | CERS

Cerus current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cerus Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.14B $0.05B 2.68
2019-03-31 $0.14B $0.05B 2.84
2018-12-31 $0.15B $0.05B 2.79
2018-09-30 $0.15B $0.04B 3.48
2018-06-30 $0.14B $0.03B 5.03
2018-03-31 $0.13B $0.02B 5.66
2017-12-31 $0.09B $0.02B 3.89
2017-09-30 $0.09B $0.02B 3.71
2017-06-30 $0.07B $0.03B 2.94
2017-03-31 $0.08B $0.03B 2.86
2016-12-31 $0.09B $0.03B 3.50
2016-09-30 $0.11B $0.02B 4.72
2016-06-30 $0.11B $0.03B 4.36
2016-03-31 $0.12B $0.02B 5.23
2015-12-31 $0.13B $0.02B 5.97
2015-09-30 $0.13B $0.02B 6.45
2015-06-30 $0.14B $0.02B 6.50
2015-03-31 $0.14B $0.02B 5.99
2014-12-31 $0.08B $0.03B 2.57
2014-09-30 $0.07B $0.02B 3.44
2014-06-30 $0.07B $0.02B 3.24
2014-03-31 $0.07B $0.03B 2.46
2013-12-31 $0.08B $0.04B 1.98
2013-09-30 $0.08B $0.04B 1.75
2013-06-30 $0.08B $0.03B 2.95
2013-03-31 $0.09B $0.03B 3.16
2012-12-31 $0.04B $0.03B 1.72
2012-09-30 $0.04B $0.03B 1.60
2012-06-30 $0.04B $0.02B 1.80
2012-03-31 $0.05B $0.03B 1.70
2011-12-31 $0.04B $0.02B 1.88
2011-09-30 $0.03B $0.01B 2.16
2011-06-30 $0.03B $0.02B 1.49
2011-03-31 $0.04B $0.02B 1.77
2010-12-31 $0.04B $0.02B 2.12
2010-09-30 $0.03B $0.02B 1.72
2010-06-30 $0.03B $0.01B 2.07
2010-03-31 $0.03B $0.01B 2.79
2009-12-31 $0.03B $0.01B 2.51
2009-09-30 $0.04B $0.02B 2.25
2009-06-30 $0.03B $0.01B 2.33
2009-03-31 $0.03B $0.01B 2.94
2008-12-31 $0.04B $0.01B 3.26
2008-09-30 $0.05B $0.01B 3.82
2008-06-30 $0.06B $0.02B 3.69
2008-03-31 $0.07B $0.01B 4.74
2007-12-31 $0.07B $0.02B 4.03
2007-09-30 $0.08B $0.02B 5.13
2007-06-30 $0.09B $0.01B 6.22
2007-03-31 $0.09B $0.01B 8.36
2006-12-31 $0.10B $0.02B 6.94
2006-09-30 $0.08B $0.02B 5.13
2006-06-30 $0.08B $0.02B 4.85
2006-03-31 $0.09B $0.02B 4.26
2005-12-31 $0.05B $0.02B 2.19
2005-09-30 $0.05B $0.01B 4.10
2005-06-30 $0.06B $0.01B 4.10
2005-03-31 $0.06B $0.02B 3.98
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.739B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.600B 28.31
Medtronic (MDT) Ireland $148.093B 20.79
Stryker (SYK) United States $82.318B 28.47
Boston Scientific (BSX) United States $58.839B 28.54
Baxter (BAX) United States $44.837B 27.19
EssilorLuxottica Societe Anonyme (ESLOY) France $31.126B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.280B 18.74
Lonza Group Ag (LZAGY) Switzerland $25.580B 0.00
Coloplast (CLPBY) Denmark $25.337B 40.45
Terumo (TRUMY) Japan $21.867B 25.14
Smith & Nephew SNATS (SNN) United Kingdom $20.565B 0.00
ResMed (RMD) United States $19.246B 36.70
Sunny Optical Technology (SNPTF) China $16.233B 0.00
Bio-Rad Laboratories (BIO) United States $10.009B 53.66
Canopy Growth (CGC) Canada $9.229B 0.00
Insulet (PODD) United States $8.710B 516.14
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.067B 21.07
Haemonetics (HAE) United States $6.391B 48.23
Aurora Cannabis (ACB) Canada $6.010B 0.00
GN STORE NORD (GNNDY) Denmark $5.608B 28.98
GW Pharmaceuticals (GWPH) United Kingdom $4.399B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.046B 67.17
NuVasive (NUVA) United States $3.422B 27.28
ICU Medical (ICUI) United States $3.306B 21.44
Hutchison China MediTech (HCM) China $2.938B 0.00
Quidel (QDEL) United States $2.835B 28.16
National Vision Holdings (EYE) United States $2.466B 53.22
Agios Pharmaceuticals (AGIO) United States $2.241B 0.00
Cardiovascular Systems (CSII) United States $1.803B 0.00
Aphria (APHA) $1.669B 0.00
VAREX IMAGING (VREX) United States $1.137B 26.19
AtriCure (ATRC) United States $0.971B 0.00
Lantheus Holdings (LNTH) United States $0.933B 24.52
Omeros (OMER) United States $0.898B 0.00
Phibro Animal Health (PAHC) United States $0.848B 13.79
Eagle Pharmaceuticals (EGRX) United States $0.809B 20.62
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.762B 18.01
LeMaitre Vascular (LMAT) United States $0.692B 41.03
MacroGenics (MGNX) United States $0.664B 0.00
Quanterix (QTRX) United States $0.664B 0.00
TG Therapeutics (TGTX) United States $0.644B 0.00
Surmodics (SRDX) United States $0.629B 119.64
OraSure Technologies (OSUR) United States $0.469B 21.70
Owens & Minor (OMI) United States $0.447B 13.40
Meridian Bioscience (VIVO) United States $0.419B 13.09
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.414B 0.00
BioLife Solutions (BLFS) United States $0.372B 122.19
Utah Medical Products (UTMD) United States $0.371B 27.16
United Health Products (UEEC) United States $0.323B 0.00
Zynex (ZYXI) United States $0.278B 29.52
Bovie Medical (APYX) United States $0.255B 0.00
Rockwell Medical (RMTI) United States $0.186B 0.00
Cytosorbents (CTSO) United States $0.172B 0.00
Vapotherm (VAPO) United States $0.165B 0.00
Fonar (FONR) United States $0.151B 7.96
Chimerix (CMRX) United States $0.134B 0.00
Female Health (VERU) United States $0.125B 0.00
Chembio Diagnostics (CEMI) United States $0.113B 0.00
United-Guardian (UG) United States $0.089B 21.05
Surface Oncology (SURF) United States $0.058B 0.00
Nephros (NEPH) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.029B 0.00
Senestech (SNES) United States $0.027B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00